Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-01-04 9:43 pm Purchase |
2021-12-31 | 13G | Globus Maritime Limited GLBS |
SABBY MANAGEMENT LLC | 1,026,649 11.000% |
710,117 (+224.34%) |
Filing History |
| 2022-01-04 9:23 pm Sale |
2021-12-31 | 13G | Gene Biotherapeutics, Inc. CRXM |
SABBY MANAGEMENT LLC | 0 0.000% |
-1,435,917 (Position Closed) |
Filing History |
| 2022-01-04 9:21 pm Sale |
2021-12-31 | 13G | GeoVax Labs, Inc. GOVX |
SABBY MANAGEMENT LLC | 0 0.000% |
-25,152 (Position Closed) |
Filing History |
| 2022-01-04 9:18 pm Purchase |
2021-12-31 | 13G | Cingulate Inc. CING |
SABBY MANAGEMENT LLC | 3,693 11.000% |
1,181 (+47.05%) |
Filing History |
| 2022-01-04 9:16 pm Sale |
2021-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
SABBY MANAGEMENT LLC | 3,095,410 11.000% |
-2,618,876 (-45.83%) |
Filing History |
| 2022-01-04 9:13 pm Purchase |
2021-12-31 | 13G | Context Therapeutics Inc. CNTX |
SABBY MANAGEMENT LLC | 1,230,830 11.000% |
230,830 (+23.08%) |
Filing History |
| 2022-01-04 9:11 pm Purchase |
2021-12-31 | 13G | Tantech Holdings Ltd TANH |
SABBY MANAGEMENT LLC | 645 11.000% |
4 (+0.55%) |
Filing History |
| 2022-01-04 9:08 pm Sale |
2021-12-31 | 13G | Qualigen Therapeutics, Inc. QLGN |
SABBY MANAGEMENT LLC | 0 0.000% |
-3,920 (Position Closed) |
Filing History |
| 2022-01-04 9:06 pm Purchase |
2021-12-31 | 13G | HeartBeam, Inc. BEAT |
SABBY MANAGEMENT LLC | 483,320 11.000% |
83,320 (+20.83%) |
Filing History |
| 2022-01-04 4:00 pm Sale |
2021-12-31 | 13G | Bluejay Diagnostics, Inc. BJDX |
SABBY MANAGEMENT LLC | 122 11.000% |
-36 (-22.92%) |
Filing History |
| 2022-01-04 3:40 pm Sale |
2021-12-31 | 13G | BioRestorative Therapies, Inc. BRTX |
SABBY MANAGEMENT LLC | 174,300 11.000% |
-50,700 (-22.53%) |
Filing History |
| 2022-01-04 3:25 pm Purchase |
2021-12-31 | 13G | Recon Technology, Ltd. RCON |
SABBY MANAGEMENT LLC | 149,650 11.000% |
72,251 (+93.35%) |
Filing History |
| 2022-01-04 11:31 am Sale |
2021-12-31 | 13G | Virpax Pharmaceuticals, Inc. VRPX |
SABBY MANAGEMENT LLC | 3,507 11.000% |
-493 (-12.32%) |
Filing History |
| 2022-01-04 11:08 am Purchase |
2021-12-31 | 13G | Aditxt, Inc. ADTX |
SABBY MANAGEMENT LLC | 0 11.000% |
0 (+12.18%) |
Filing History |
| 2022-01-04 10:43 am Sale |
2021-12-31 | 13G | PharmaCyte Biotech, Inc. PMCB |
SABBY MANAGEMENT LLC | 260,928 11.000% |
-985,317 (-79.06%) |
Filing History |
| 2022-01-04 10:24 am Sale |
2021-12-31 | 13G | Red Cat Holdings, Inc. RCAT |
SABBY MANAGEMENT LLC | 1,381,789 11.000% |
-1,183,344 (-46.13%) |
Filing History |
| 2022-01-04 10:06 am Sale |
2021-12-31 | 13G | ENGlobal Corporation ENG |
SABBY MANAGEMENT LLC | 0 0.000% |
-297,619 (Position Closed) |
Filing History |
| 2022-01-03 9:58 pm Sale |
2021-12-31 | 13G | Polished.com Inc. POL |
SABBY MANAGEMENT LLC | 6,150 11.000% |
-171,626 (-96.54%) |
Filing History |
| 2022-01-03 9:47 pm Sale |
2021-12-31 | 13G | Cocrystal Pharma, Inc. COCP |
SABBY MANAGEMENT LLC | 478,177 11.000% |
-333,490 (-41.09%) |
Filing History |
| 2022-01-03 9:37 pm Purchase |
2021-12-31 | 13G | Bit Brother Ltd | SABBY MANAGEMENT LLC | 2,471,878 11.000% |
2,471,878 (New Position) |
Filing History |